With AI applications and agents increasing the demand for trusted real-time data, IBM plans to combine the Confluent platform with its AI infrastructure software and automation systems. IBM has struck ...
A cancer patient enrolled in a clinical trial today might wait months before regulators ever see the safety data generated by their treatment. The FDA wants to change that, and it has started running ...